Association between the serum level of testosterone and other comorbidities in obstructive sleep apnea;Modificǎri ale nivelului seric de testosteron asociate comorbiditǎţilor sindromului de apnee în somn obstructiv

Pneumologia

Volumn 61, Issue 2, 2012, Pages 98-101

  Bercea, Raluca ^a   Bercea, Bogdan ^b   Mihǎescu, Traian ^a  

^a Clinical Hospital of Pneumology   (Romania)

^b CI Parhon Hospital   (Romania)

Author keywords

Comorbidities; OSAS; Testosterone

Indexed keywords

BIOLOGICAL MARKER; TESTOSTERONE;

BLOOD; HUMAN; HYPOGONADISM; MALE; POSITIVE END EXPIRATORY PRESSURE; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPOGONADISM; MALE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84862557663     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Iber C, Ancoli-Israel S, Chesson A etc. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
2. Pastuszko A, Wilson DF, Erecinska. M. Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH. J Neurochem 1982;38:1657-1667. (Pubitemid 12030319)
3. Grunstein RR, Stewart DA, Lloyd H etc. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 1996;19:774-782. (Pubitemid 27131927)
4. Hanafy HM. Testosterone therapy and obstructive sleep apnea: Is there a real connection? J Sex Med 2007;4:1241-1246. (Pubitemid 47337667)
5. Howard JM. Testosterone and Sleep: Support for Sleep Theory. Am J Resp Crit Care Med 1994;149:530.
6. Howard JM. Testosterone and Sleep: Support for Sleep Theory. J Clin Endocrinol 1985;22:713.
7. Mateika JH, Omran Q, Rowley JA etc. Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males. J Physiol 2004;561:637-646. (Pubitemid 39646549)
8. Luboshitzky R, Aviv A, Hefetz A etc. Decreased Pituitary-Gonadal Secretion in Men with Obstructive Sleep Apnea. J Clin Endocrinol Metab 2002;87:3394-3398. (Pubitemid 34816395)
9. Grunstein RR, Handelsman DJ, Lawrence SJ etc. Neuroendocrine Dysfunction in Sleep Apnea: Reversal by Continuous Positive Airways Pressure Therapy. J Clin Endocrinol Metab 1989;68:2352-2358.
10. Luboshitzky R, Lavie L, Shen-Orr Z etc. Pituitary-gonadal function in men with obstructive sleep apnea. The effect of continuous positive airways pressure treatment. Neuro Endocrinol Lett 2003;24:463-467. (Pubitemid 38035098)
11. Zoung T, Palta M, Dempsey J etc. Occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235. (Pubitemid 23115702)
12. Bearpark H, Elliott L, Grunstein R etc. Snoring and sleep apnea: a population study in Australian men. Am J Respir Crit Care Med 1995;151:1459-1465.
13. Snyder PJ. Hypogonadism in elderly men: what to do until the evidence comes. N Engl J Med 2004;350:440-442. (Pubitemid 38133763)
14. Trummer H, Habermann H, Haas J etc. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 2002;17:1554-1559. (Pubitemid 34661807)
15. Handelsman DJ, Staraj S. Testicular size: the effect of aging, malnutrition and illness. J Androl 1985;6:144-151.
16. Harman SM, Metter EJ, Tobin JD etc. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731. (Pubitemid 32207487)
17. Grunstein RR, Wilcox I, Yang TS etc. Snoring and sleep apnea in men: association with central obesity and hypertension. Int J Obesity 1993;17:533-540. (Pubitemid 23269132)
18. Feldman HA, Longcope C, Derby CA etc. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002;87:589-598. (Pubitemid 34158223)
19. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH) - insulin-like growth factor type 1 (IGF-1) axis; predominant impact of age, obesity, gonadal function and sleep. Sleep 1996;19:S221-S224. (Pubitemid 27138534)
20. Laghi F, Antonescu-Turcu A, Collins E etc. Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am J Respir Crit Care Med 2005;171:728-733. (Pubitemid 40471143)
21. Pastuszko A, Wilson DF, Erecinska. M. Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH. J Neurochem 1982;38:1657-1667. (Pubitemid 12030319)
22. Sutton JR. Effect of acute hypoxia on the hormonal response to exercise. J Appl Physiol 1997;42:587-592.
23. Grunstein RR, Stewart DA, Lloyd H etc. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 1996;19:774-782. (Pubitemid 27131927)
24. Yardimci S, Atan A, Delibasi T etc. Long-term effects of cigarette-smoke exposure on plasma testosterone, luteinizing hormone and follicle-stimulating hormone levels in male rats. Br J Urol 1997;79:66-69. (Pubitemid 28318847)
25. Hintikka J, Niskanen L, Koivumaa-Honkanen H. Hypogonadism, decreased sexual desire and long-term depression in middle-aged men. J Sex Med 2009;6:2049-2057.
26. McCall WV, Harding D, O'Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med 2006;2:424-426. (Pubitemid 44763802)
27. Schröder CM, O'Hara R. Depression and Obstructive Sleep Apnea. Ann Gen Psychiatry 2005;4:13.
28. De Wit LM, Fokkema M, van Straten A etc. Depressive and anxiety disorders and the association with obesity, physical, and social activities. Depress Anxiety 2010;27:1057-1065.
29. Means MK, Lichtenstein KL, Edinger JD etc. Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath 2003;7:31-42. (Pubitemid 36553403)
30. Abstr. in: Bercea RM, Cojocaru E, Mihaescu T. Secondary hypogonadism induced by severe obstructive sleep apnea syndrome (OSAS) and results after two months CPAP treatment, Eur Respir J 2010 vol 36, suppl 54.
31. Van Vliet M, Spruit MA, Verleden G etc. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1105-1111. (Pubitemid 43066645)
32. Debigare R, Marquis K, Cote CH etc. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003;124:83-89. (Pubitemid 36851335)
33. Lovin S, Bercea R, Mihaescu T etc. Body composition in obstructive sleep apnea-hypopnea syndrome Bio-impedance reflects the severity of sleep apnea. Multidiscip Resp Med 2010;5:44-49.
34. Svartberg J, Aasebø U, Hjalmarsen A etc. Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med 2004 98:906-913. (Pubitemid 39069342)
35. Andersen ML, Alvarenga TF, Mazaro-Costa R etc. The association of testosterone, sleep and sexual function in men and women. Brain Res 2011;1416:80-104.
36. Zhuravlev VN, Frank MA, Gomzhin AI. Erectile dysfunction and obstructive sleep apnea syndrome. Urologiia 2008;35:37-39.
37. Margel D, Cohen M, Livne PM etc. Severe, but not mild, obstructive sleep apnea syndrome is associated with erectile dysfunction. Urology 2004;63:545-549.
38. Sandblom RE, Matsumoto AM, Scoene RB etc. Obstructive sleep apnea induced by testosterone administration. N Engl J Med 1983;308:508-510. (Pubitemid 13195480)
39. Khawam EA, Laurencic G, Malone DA. Side effects of antidepressants: An overview. Cleve Clin J Med 2006;73:351-361.
40. Carter R, Watenpaugh DE. Obesity and obstructive sleep apnea: Or is it OSA and obesity? Pathophysiology 2008;15:71-77.